1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Orchid Pharma Limited

Orchid Pharma Limited

ORCHPHARMA.BO
Orchid Pharma LimitedIN flagBombay Stock Exchange
944.50
INR
+11.90
- -
47.88BMarket Cap

Total Valuation

Orchid Pharma Limited carries a market capitalization of 47.88B, placing it among publicly traded companies globally. Its enterprise value stands at 27.03B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap47.88B
Enterprise Value27.03B

Share Statistics

Orchid Pharma Limited currently has 50.72M shares outstanding.

Shares Outstanding50.72M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Orchid Pharma Limited trades at a trailing price-to-earnings ratio of 119.11. The price-to-sales ratio is 2.99, and the price-to-book ratio stands at 47.80.

PE Ratio119.11
PS Ratio2.99
PB Ratio47.80
P/TBV Ratio2.00
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Orchid Pharma Limited trades at an EV/EBITDA multiple of 32.72 and an EV/FCF ratio of 203.87. The EV/Sales ratio of 3.33 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 32.72 provides insight into valuation relative to core operating earnings.

EV / Sales3.33
EV / EBITDA32.72
EV / EBIT32.72
EV / FCF203.87

Financial Position

Orchid Pharma Limited maintains a current ratio of 2.45, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 28.16, indicating elevated leverage, while an interest coverage ratio of 6.23 demonstrates adequate ability to service its debt obligations.

Current Ratio2.45
Quick Ratio0.30
Debt / Equity28.16
Debt / EBITDA4.39
Interest Coverage6.23

Financial Efficiency

Orchid Pharma Limited posts a return on equity of 103.03 and a return on invested capital of 5.41.

Return on Equity (ROE)103.03
Return on Assets (ROA)1.13
Return on Invested Capital (ROIC)5.41
Return on Capital Employed (ROCE)-4.67
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.31

Taxes

Over the trailing twelve months, Orchid Pharma Limited has paid 17,000.00 in income taxes, reflecting an effective tax rate of 0.01.

Income Tax17,000.00
Effective Tax Rate0.01

Stock Price Statistics

Orchid Pharma Limited's stock has gained approximately 28.0244% over the past 52 weeks. The 50-day moving average sits at 806.57, while the 200-day moving average is 725.91.

Beta (5Y)N/A
52-Week Price Change28.0244%
50-Day Moving Average806.57
200-Day Moving Average725.91
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Orchid Pharma Limited generated 8.11B in revenue and converted that into 203.54M in net income, yielding earnings per share of 3.78. EBITDA reached 826.12M, while operating income came in at 826.12M.

Revenue8.11B
Gross Profit2.85B
Operating Income826.12M
Pretax Income210.17M
Net Income203.54M
EBITDA826.12M
EBIT826.12M
Earnings Per Share (EPS)3.78

Balance Sheet

Orchid Pharma Limited holds 840.74M in cash and equivalents against 3.63B in total debt, resulting in a net debt position of 3.50B. Total book value stands at 507.19M, with working capital of 4.05B providing operational flexibility.

Cash & Cash Equivalents840.74M
Total Debt3.63B
Net Debt3.50B
Equity (Book Value)507.19M
Book Value Per Share10.01
Working Capital4.05B

Margins

Orchid Pharma Limited operates with a gross margin of 35.18, reflecting its pricing power and cost economics. The operating margin of 10.18 and net profit margin of 2.51 provide insight into operational efficiency.

Gross Margin35.18
Operating Margin10.18
Pretax Margin2.59
Profit Margin2.51
EBITDA Margin10.18

Scores

Orchid Pharma Limited posts an Altman Z-Score of 3.19, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score3.19